Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3239.06	589.69	17.66
Graham Fair Price	-13.87	39.13	45.43
PEG	-36.36	-0.54	-0.40
Price/Book	24.04	1.27	1.02
Price/Cash Flow	-34.68	2.52	-3.86
Prices/Earnings	51.64	13.91	9.18
Price/Sales	-56.08	4.13	9.40
Price/FCF	-34.68	2.52	-3.86
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-98.84	< 0.005	0.32
ROA	-27.87	< 0.005	< 0.005
ROE	0.03	0.02	-18.20
ROIC	0.01	< 0.005	-98.06
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	1.16	0.02	6401.38
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.23	-1.03	-355.86
EPS QOQ	-0.23	-0.26	-11.20
FCF QOQ	0.42	2.74	552.84
Revenue QOQ	-0.03	1.58	5939.75
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	91.29	34.19	-62.55
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.56	0.72	27.41
Quick Ratio	0.19	-0.19	-2.66
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	57.34	54.60	-4.78
Cash	81.61	-111.42	36.53
Capex	-2.11	-0.21	90.06
Free Cash Flow	-15.22	27.52	80.84
Revenue	6.24	16.79	168.95
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.19	0.24	26.14
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.00	169.39	1782.31
Naive Interpretation	Member

06 - Financial Health · Bad

Rating